![]() |
OICR invests $415,000 to develop radiolabelled insulin probe for early detection of b
Dr. Tom Hudson, President and Scientific Director of the Ontario Institute for Cancer Research today announced an investment of $415,000 towards the development of a radiolabelled insulin probe for the early detection of breast cancer.
More... |
| All times are GMT -7. The time now is 05:21 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021